PUBLIC CONTRACT · 2024
4180258/2024-aq. Central U20 - Ustecinumab 45 mg (90 mgml ser pré-cheia 0.5 ml) sol inj
- Contract value
- €7,038.40
- Signed on
- 18 September 2024
- Procedure
- Ao abrigo de acordo-quadro (art.º 259.º)
This page lays out the fields published on Portal BASE and says when a field is unavailable. It is not an assessment of the contract's merit, legality or impact.
Record 11315086PUBLISHED SUBJECT
4180258/2024-AQ. CENTRAL U20 - USTECINUMAB 45 MG (90 MGML SER PRÉ-CHEIA 0.5 ML) SOL INJ
Parties involved
- Place of performance
- Portugal, Setúbal, Barreiro
- NUTS region
- Not stated
WHO BID
Awardee and competitors
Companies that IMPIC lists as the awardee and as competitors in this procedure.
- Awardee
- CICLUM FARMA UNIPESSOAL, LDA · Tax ID 504362674
Values and timeline
- Contract price
- €7,038.40
- Procedure base price
- €7,038.40
- Total effective price
- €7,038.40
- Publication date
- 28 March 2025
- Award date
- 18 September 2024
- Signing date
- 18 September 2024
- Performance period
- 104 days
The contract price is the value agreed in the contract, not the amount paid.
Procedure and framework
- Contract type
- Aquisição de bens móveis
- Procedure type
- Ao abrigo de acordo-quadro (art.º 259.º)
- Award criterion
- Monofator
- CPV code
- 33600000-6 - Produtos farmacêuticos
- Legal basis
- Artigo 259.º do Código dos Contratos Públicos
- Regime
- Código dos Contratos Públicos (DL111-B/2017) e Lei n.º 30/2021, de 21.05
- Framework agreement
- 671/2023 - Concurso público internacional para formação do acordo quadro de medicamentos diversos
- Centralised procedure
- No
- Environmental criterion
- No
- Notice
- Not stated
- Procedure identifier
- 7539779
Compare with other contracts
Search the same body, supplier, place or type of service to understand the context of the published index.